SARA SCALIA: Open Payments
NPI 1396317509 · OLD BRIDGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,181 in 230 payments from 21 companies in 2025. Trend: 2023 $1,008 · 2024 $2,155 · 2025 $4,181
Food & beverage: $3,974Education: $207
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $621 |
| Incyte Corporation | 25 | $608 |
| Regeneron Healthcare Solutions, Inc. | 15 | $429 |
| ABBVIE INC. | 27 | $393 |
| Arcutis Biotherapeutics, Inc. | 16 | $284 |
| Galderma Laboratories, L.P. | 17 | $243 |
| Organon LLC | 7 | $209 |
| UCB, Inc. | 13 | $196 |
| Lilly USA, LLC | 12 | $185 |
| Novartis Pharmaceuticals Corporation | 6 | $176 |
Products named: TREMFYA, Opzelura, DUPIXENT, Zoryve, SKYRIZI, Bimzelx, LIBTAYO, RINVOQ.
Industry payments across NJ — which companies pay providers there.
